REPLIGEN CORP (RGEN)

Repligen to Report Second Quarter 2024 Financial Results

Webcast and Conference Call to Be Held Tuesday, July 30, 2024, at 8:30 a.m. ET...

Bargain Hunters Take Note: Insider Cluster-Buying At RGEN

Repligen Announces CEO Transition Plan

Tony J. Hunt to Transition from Chief Executive Officer to Executive Chair, Olivier Loeillot Appointed to Role of President and Chief Executive Officer,...

Relative Strength Alert For Repligen

Repligen Larger Than S&P 500 Component Generac Holdings

Repligen Corporation to Present at Upcoming June Investor Conferences

WALTHAM, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology...

RGEN Makes Bullish Cross Above Critical Moving Average

Repligen Corporation to Present at Upcoming May Investor Conferences

WALTHAM, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology...

RGEN Stock Earnings: Repligen Misses EPS, Beats Revenue for Q1 2024

RGEN stock results show that Repligen missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Repligen Reports First Quarter 2024 Financial Results

Reports first quarter revenue of $151 million Increased new modalities revenue by 16% year-over-yearIncreased Filtration (non-COVID) revenue by 12%...

Notable Two Hundred Day Moving Average Cross - RGEN

Relative Strength Alert For Repligen

Repligen Appoints Maggie A. Pax to Board of Directors

WALTHAM, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors of life...

Repligen Reports Fourth Quarter and Full Year 2023 Financial Results

Reports fourth quarter revenue of $156 million and full year revenue of $639 million Continued strength in orders with fourth quarter book-to-bill ratio of...

Repligen Larger Than S&P 500 Component Bio-Techne

Interesting RGEN Put And Call Options For January 2025

Repligen to Report Fourth Quarter and Full Year 2023 Financial Results

Webcast and Conference Call to Be Held Wednesday, February 21, 2024, at 8:30 a.m. ET...

Noteworthy Monday Option Activity: ADM, NFE, RGEN

Danaher stock rises as Sartorius beats in Q4 (NYSE:DHR)

U.S. life sciences toolmakers Danaher (DHR), Repligen (REGN), and Bio-Rad (BIO) see gains as German peer Sartorius (SARTF) posts strong Q4 2023 results. Read more here.

Commit To Purchase Repligen At $170, Earn 37.3% Annualized Using Options

Noteworthy Friday Option Activity: GM, RGEN, LUV

How Good Is Your Market Cap Knowledge?

A company with a $50 price per share might have a million shares outstanding or a billion shares outstanding. And unless you know, you don't know the price tag of the stock you're about to buy.

Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference

WALTHAM, Mass., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology...

Repligen to issue $600M convertible senior notes (NASDAQ:RGEN)

Repligen announces $600M convertible senior notes issuance, boosting its year-end cash and cash equivalent guidance to $717M-$727M.

Repligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1.00% Convertible Senior Notes Due 2028 Through Exchange and New Subscription Agreements

WALTHAM, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) today announced that on December 6, 2023, it entered into privately...

Repligen Larger Than S&P 500 Component Universal Health Services

UPDATE – Repligen Announces Publication of the Company’s 2022 Sustainability Report

WALTHAM, Mass., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology...

Repligen Announces Publication of the Company’s 2022 Sustainability Report

WALTHAM, Mass., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology...